Belatacept Therapy for the Failing Renal Allograft
Status: Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 03 Dec 2018
Price : $35 *
At a glance
- Drugs Belatacept (Primary) ; Ciclosporin; Mycophenolate mofetil; Prednisone; Tacrolimus
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 27 Nov 2018 Planned End Date changed from 1 Aug 2019 to 1 Jan 2020.
- 27 Nov 2018 Planned primary completion date changed from 1 Aug 2018 to 1 Jan 2020.
- 13 Dec 2017 Status changed from recruiting to active, no longer recruiting.